about
Seasonal variations of urate in a Swedish adult populationImportance of synovial fluid aspiration when injecting intra-articular corticosteroidsRandomised controlled study of postinjection immobilisation after intra-articular glucocorticoid treatment for wrist synovitisChanges of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis.Glucocorticoid resorption and influence on the hypothalamic-pituitary-adrenal axis after intra-articular treatment of the knee in resting and mobile patientsImportance of immobilization after intraarticular glucocorticoid treatment for elbow synovitis: a randomized controlled study.Does modern treatment of early rheumatoid arthritis reduce the need for intra-articular glucocorticoids?Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies.Serum levels of sex steroid hormones and matrix metalloproteinases after intra-articular glucocorticoid treatment in female patients with rheumatoid arthritis.Serum concentrations of hyaluronan and proteoglycan in joint disease. Lack of associationProresid in the long-term treatment of rheumatoid arthritisTreatment of rheumatoid patients with Proresid[A fatal drug-induced autoimmune syndrome]Bacterial arthritis in a Swedish health districtEndocrine effects of the podophyllotoxine derivative drug CPH 82 (Reumacon) in patients with rheumatoid arthritisCathepsin S and cathepsin L in serum and synovial fluid in rheumatoid arthritis with and without autoantibodiesAltered levels of exhaled nitric oxide in rheumatoid arthritisAcupressure treatment for methotrexate-induced nausea in arthritis patientsDosing of intra-articular triamcinolone hexacetonide for knee synovitis in chronic polyarthritis: a randomized controlled study
P50
Q33840512-2844F78C-F0D0-4D37-9A8E-85BB0CCE62E7Q35549191-1B63FD3F-E284-4505-A4B3-BC3AA0EC3B0EQ35552081-E34F5D86-6AFA-486B-B93D-07418E229733Q35555050-4A286AC3-7CA4-4EFB-BF3C-169FF3D071F5Q35637369-8B66F375-BC39-4308-B75D-5D5DE55C7678Q39874205-8A371127-6B3E-4B5B-A831-82CD20953E99Q44718935-BC39B48E-BF7C-499A-8C70-74A62BB950FCQ50533824-6E1F2A33-7250-40E7-B7A0-0402B7271364Q51736902-834C63BD-14E6-4AC8-B5E7-16EE7E0DA939Q67815717-AF55072A-8BD5-42F5-955C-ABB7D1655DE9Q68043177-9AA0A3AD-F0DD-4A2D-8FAD-DE0C9D7D2551Q68777829-F260B1A6-650C-46AB-AD21-C16C9368E0E5Q69757545-E756CEFE-C134-41AE-9CA9-13D661CD5AC4Q73461971-E8829B8C-286B-431B-B39C-CC717C3ABBD9Q73703154-D5E9DE57-0B56-402C-BAE4-7B710D393280Q85345560-53F31E33-CC52-4617-A2D9-81207FD364A4Q87897227-AF15D166-070F-4764-9A3A-C2FA4E4B4473Q90223669-EF4F87D4-DB7C-4352-AA8C-2D3832D16F7BQ92185363-778DE9B3-0DD6-46AE-AD2E-D1596F0FEC2A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
T Weitoft
@ast
T Weitoft
@en
T Weitoft
@es
T Weitoft
@nl
type
label
T Weitoft
@ast
T Weitoft
@en
T Weitoft
@es
T Weitoft
@nl
prefLabel
T Weitoft
@ast
T Weitoft
@en
T Weitoft
@es
T Weitoft
@nl
P106
P31
P496
0000-0002-8371-7116